Journal of Advanced Biotechnology and Experimental Therapeutics
Peer Review (Double-blind Peer review)
✅ After the manuscript is received, it is primarily checked by the Editor-in-Chief. a) If the manuscript is not well formatted, it is sent back to the corresponding author. b) If the content is not satisfactory or does not match the scopes of JABET, the manuscript is sent back as rejected instantly. c) Upon passing the preliminary screening, the manuscript is sent to at least two expert peer reviewers.
✅ An invitation for each reviewer is sent by e-mail from the journal management system. Only the title and abstract of the manuscript are included in the e-mail invitation. After accepting the invitation, the reviewer gets full access to the entire manuscript (at least 3 weeks are allowed). Information about the reviewers are kept confidential (closed).
✅ After the completion of the peer-review process, the revised manuscript is sent to the section /associate editor for critical checking and seeking the primary comments whether the manuscript can be accepted or it is sent for revision. The revision time allowed for individual manuscript may vary depending on the extent of work as suggested by the reviewers. A final decision on a manuscript is finally made by the Editor-in-Chief considering the comments of the expert reviewers and the section editor.
✅ The decision may be any one of the following:
👉 Accept (with or without editorial revision)
👉 Suggest the authors for more revision (at least 4 weeks)
👉Reject, typically on grounds of specialist interest, lack of novelty, insufficient conceptual advance or major technical and/or interpretational problem.
✅ Approximately, the time from receipt to acceptance of the manuscript is 8-10 weeks.
✅ The whole the submission, peer-review, and editorial processes are maintained through the journal management system.